Annual CFO
-$32.69 M
-$10.52 M-47.41%
31 December 2023
Summary:
Elicio Therapeutics annual cash flow from operations is currently -$32.69 million, with the most recent change of -$10.52 million (-47.41%) on 31 December 2023. During the last 3 years, it has fallen by -$15.99 million (-95.72%). ELTX annual CFO is now -251.76% below its all-time high of -$9.29 million, reached on 31 December 2019.ELTX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$7.27 M
+$1.65 M+18.53%
30 September 2024
Summary:
Elicio Therapeutics quarterly cash flow from operations is currently -$7.27 million, with the most recent change of +$1.65 million (+18.53%) on 30 September 2024. Over the past year, it has dropped by -$2.09 million (-40.29%). ELTX quarterly CFO is now -190.16% below its all-time high of -$2.51 million, reached on 31 March 2020.ELTX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$38.22 M
-$2.09 M-5.78%
30 September 2024
Summary:
Elicio Therapeutics TTM cash flow from operations is currently -$38.22 million, with the most recent change of -$2.09 million (-5.78%) on 30 September 2024. Over the past year, it has dropped by -$15.42 million (-67.63%). ELTX TTM CFO is now -1424.55% below its all-time high of -$2.51 million, reached on 31 March 2020.ELTX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELTX Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -47.4% | -40.3% | -67.6% |
| 3 y3 years | -95.7% | -19.8% | -529.4% |
| 5 y5 years | - | - | - |
ELTX Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -95.7% | at low | -40.3% | +40.0% | -529.4% | at low |
| 5 y | 5 years | -251.8% | at low | -190.2% | +40.0% | -1424.5% | at low |
| alltime | all time | -251.8% | at low | -190.2% | +40.0% | -1424.5% | at low |
Elicio Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$7.27 M(-18.5%) | -$38.22 M(+5.8%) |
| June 2024 | - | -$8.93 M(-26.3%) | -$36.13 M(-1.5%) |
| Mar 2024 | - | -$12.12 M(+22.5%) | -$36.68 M(+12.2%) |
| Dec 2023 | -$32.69 M | -$9.89 M(+90.8%) | -$32.69 M(+43.4%) |
| Sept 2023 | - | -$5.18 M(-45.3%) | -$22.80 M(+29.4%) |
| June 2023 | - | -$9.47 M(+16.4%) | -$17.61 M(+116.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$8.14 M(+34.0%) | -$8.14 M(+34.0%) |
| Dec 2022 | -$22.18 M(-7.4%) | - | - |
| Dec 2021 | -$23.94 M(+43.3%) | - | - |
| Mar 2021 | - | -$6.07 M(+142.2%) | -$6.07 M(+142.2%) |
| Dec 2020 | -$16.70 M(+79.7%) | - | - |
| Mar 2020 | - | -$2.51 M | -$2.51 M |
| Dec 2019 | -$9.29 M | - | - |
FAQ
- What is Elicio Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Elicio Therapeutics?
- What is Elicio Therapeutics annual CFO year-on-year change?
- What is Elicio Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Elicio Therapeutics?
- What is Elicio Therapeutics quarterly CFO year-on-year change?
- What is Elicio Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Elicio Therapeutics?
- What is Elicio Therapeutics TTM CFO year-on-year change?
What is Elicio Therapeutics annual cash flow from operations?
The current annual CFO of ELTX is -$32.69 M
What is the all time high annual CFO for Elicio Therapeutics?
Elicio Therapeutics all-time high annual cash flow from operations is -$9.29 M
What is Elicio Therapeutics annual CFO year-on-year change?
Over the past year, ELTX annual cash flow from operations has changed by -$10.52 M (-47.41%)
What is Elicio Therapeutics quarterly cash flow from operations?
The current quarterly CFO of ELTX is -$7.27 M
What is the all time high quarterly CFO for Elicio Therapeutics?
Elicio Therapeutics all-time high quarterly cash flow from operations is -$2.51 M
What is Elicio Therapeutics quarterly CFO year-on-year change?
Over the past year, ELTX quarterly cash flow from operations has changed by -$2.09 M (-40.29%)
What is Elicio Therapeutics TTM cash flow from operations?
The current TTM CFO of ELTX is -$38.22 M
What is the all time high TTM CFO for Elicio Therapeutics?
Elicio Therapeutics all-time high TTM cash flow from operations is -$2.51 M
What is Elicio Therapeutics TTM CFO year-on-year change?
Over the past year, ELTX TTM cash flow from operations has changed by -$15.42 M (-67.63%)